In response to such a serious pneumonia epidemic in India, a group of people are gradually worried: Can you buy Indian generic drugs? Most of these people are cancer patients and their relatives.
Yes, India is known as the "global pharmaceutical factory", and the relevant industrial chain of generic drugs is very sound. However, with the outbreak of pneumonia, Indian pharmaceutical companies have basically suspended business, and patients who have to take Indian generic drugs for a long time in China have gradually fallen into deep anxiety.
However, some professionals said that there is no need to worry too much. The epidemic situation of pneumonia in India is serious, which does little harm to most generic drugs in China. In recent years, Indian countries around China, such as Bangladesh, Myanmar and Viet Nam, are vigorously promoting the generic drug industry chain.
First of all, generic drugs are not a panacea.
On the other hand, there is no need to "deify" Indian generic drugs, and even a dilemma may arise.
Two years ago, Lin, an oncologist in Liaocheng, strongly recommended a new counterfeit anticancer drug "Katini" to their patients. The patient has prostate cancer and small cell lung cancer. He died tragically after a period of treatment. Then, the relatives of patients gradually questioned the professional ability of doctors and the authenticity of drugs, and felt that the strong recommendation of doctors had the behavior of "drugs are not symptomatic treatment".
According to the evaluation of authoritative departments, this new anticancer drug carboplatin is indeed a fake and shoddy product. Finally, Dr. Chen was punished by the hospital outpatient service, and the generic drug "merchant" was also detained.
After the generic drug "merchant" was criminally detained, other patients could not buy medicine, which delayed the medical treatment and was very anxious. Public anger against relatives of suspected patients continues on the Internet.
Suspected doctor said "poor". Capotinib just didn't meet the requirements of our country, and it was regarded as a "fake and shoddy product", but its ingredients were true. "he prescribed this medicine and never violated the initial intention of rescue."
Regarding this matter, Wang Mingwei, the head of China Drug Selection Management Center, said that carboplatin management in foreign countries is reasonable, legal and compliant, and the scope of application allowed by FDA is medullary carcinoma of thyroid cyst and renal tumor. But in China, carboplatin has not been approved for use. It is only used as an experimental drug. In this case, the patient bought not the original British medicine, but the Indian generic medicine. After investigation, carboplatin is not allowed in India.
This incident caused discussion among netizens, some people used it and some people resisted it. But back to reality, we have to "deify" generic drugs, so that we can look at its efficacy more objectively.
Second, why are Indian generic drugs so cheap? Who is right and who is wrong, we won't discuss it. It is also involuntary for patients to use Indian generic drugs with certain risks without the original drug. India's generic drugs are far less expensive than the original drugs, and the efficacy is likely to be similar.
In general, the fixed cost of product research and development of a drug is about $2.6 billion, so it is necessary to set a higher price for the drug during the intellectual property protection period in order to recover the cost. However, "patent right" is not suitable for India. In India, even in Myanmar, Bangladesh and other countries, in order to better ensure residents' health and national defense security, they all have the right to "compulsory licensing of patent rights", that is, compulsory licensing is taken for most drugs, and the patent rights of the original drugs are not recognized.
From 65438 to 0970, Indian patent law required that it was reasonable and legal to copy an existing molecular structure, but it was illegal to copy the production process of this molecular structure. In other words, as long as the secret recipe process is changed, the current medicine can be re-made. Therefore, under the powerful "halo", India's generic drugs are basically the same as the original drugs, but the cost is much lower and the prices are quite different.
Take sofebuvir as an example. In 20 17, sofebuvir was listed in China, and the market price was 1966 yuan/bottle, and a course of treatment cost 58,980 yuan. When treating the whole genotype, sofebuvir can not be used alone, but must be used in combination with Darcy's law. The cost of a course of treatment of dacitavir is about 20,000 yuan. Together, a course of treatment will definitely cost about 80 thousand yuan.
As we all know, in India, the price of a course of sofebuvir+dacitavir is only 7500 yuan. Even for the second and third generations, the market price only fluctuates around 8000 yuan.
For example, the market price in China is around 25,000 yuan, while the Indian version only needs 1200 yuan. Under the huge price advantage, patients certainly yearn for India's "God-like" generic drugs.
Third, behind the cheapness are security risks. Is it always good to be cheap? Everyone may be deceived by appearances. Although the price advantage of Indian generic drugs is remarkable, we have to admit that there are still many security risks. Investigative reporter Catherine? In the book "The Truth of Generic Drugs", Eban takes the Indian generic drug company Rambosi as an example to reveal the truth.
1, drug data information fraud
Generic drugs currently have a "limited quota" policy, allowing the first company to submit an application to the FDA to make a profit. Under the pressure of rights and interests, large generic drug manufacturers are willing to use false data and information. A text file submitted to FDA shows that more than 50% of drug data information is false, and some manufacturers even give up molecular biology experiments immediately.
2. The factory is a mess. The pharmaceutical industry has strict regulations on the natural environment. But after the interview, the reporter found that mosquitoes were flying all over the sky, and even birds and wild snakes appeared. What is even more frightening is that there is no problem in the equipment installation and test results of the microbial strain laboratory, but there are no samples, which proves that "data information has been tampered with" and the safety factor has been lost.
The illness has become more and more serious. Nowadays, generic drugs are getting closer to the original drugs, but there are still hidden dangers in physical and mental health and safety. Some patients got worse after taking it, and relieved after replacing the original drug, and even some people couldn't catch up with the treatment and eventually died. At this moment, "eating generic drugs" has become a gamble of life.
Although generic drugs have the reputation of "cheap and good quality", patients should be vigilant and use them carefully. Everyone expects the sales market to become more and more standardized. With normal centralized purchasing, many patients will be less worried.